Improving the affinity of SL0101 for RSK using structure-based design.

Enhanced activity of the Ser/Thr protein kinase, RSK, is associated with transformation and metastasis, which suggests that RSK is an attractive drug target. The natural product, SL0101 (kaempferol 3-O-(3″,4″-di-O-acetyl-α-L-rhamnopyranoside), has been shown to be a RSK selective inhibitor. However, the Ki for SL0101 is 1 μM with a half-life of less than 30 min in vivo. To identify analogues with improved efficacy we designed a set of analogues based on the crystallographic model of SL0101 in complex with the RSK2 N-terminal kinase domain. We identified an analogue with a 5″-n-propyl group on the rhamnose that has > 40-fold improved affinity for RSK relative to SL0101 in an in vitro kinase assay. This analogue preferentially inhibited the proliferation of the human breast cancer line, MCF-7, versus the normal untransformed breast line, MCF-10A, which is consistent with results using SL0101. However, the efficacy of the 5″-n-propyl analogue to inhibit MCF-7 proliferation was only two-fold better than for SL0101, which we hypothesize is due to limited membrane permeability. The improved affinity of the 5″-n-propyl analogue for RSK will aid in the design of future compounds for in vivo use.

[1]  Zygmunt S Derewenda,et al.  Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor. , 2012, Biochemistry.

[2]  D. Lannigan,et al.  Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability. , 2012, Bioorganic & medicinal chemistry letters.

[3]  J Downward,et al.  An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis , 2011, Oncogene.

[4]  Y. Rojanasakul,et al.  Synthesis and Evaluation of the α-d-/α-l-Rhamnosyl and Amicetosyl Digitoxigenin Oligomers as Antitumor Agents , 2011 .

[5]  Y. Rojanasakul,et al.  C5'-Alkyl Substitution Effects on Digitoxigenin α-l-Glycoside Cancer Cytotoxicity. , 2011, ACS medicinal chemistry letters.

[6]  Y. Rojanasakul,et al.  Stereochemical survey of digitoxin monosaccharides: new anticancer analogues with enhanced apoptotic activity and growth inhibitory effect on human non-small cell lung cancer cell. , 2011, ACS medicinal chemistry letters.

[7]  Y. Rojanasakul,et al.  Synthesis and Evaluation of the α-D-/α-L-Rhamnosyl and Amicetosyl Digitoxigenin Oligomers as Anti-tumor Agents. , 2011, ACS medicinal chemistry letters.

[8]  G. O'Doherty,et al.  Total synthesis of jadomycin A and a carbasugar analogue of jadomycin B. , 2010, Angewandte Chemie.

[9]  G. O'Doherty,et al.  Synthesis of several cleistrioside and cleistetroside natural products via a divergent de novo asymmetric approach. , 2010, Organic letters.

[10]  Hung‐wen Liu,et al.  A de novo approach to the synthesis of glycosylated methymycin analogues with structural and stereochemical diversity. , 2010, Organic letters.

[11]  Derek K. Rogalsky,et al.  A Direct Comparison of the Anticancer Activities of Digitoxin MeON-Neoglycosides and O-Glycosides: Oligosaccharide Chain Length-Dependent Induction of Caspase-9-Mediated Apoptosis. , 2010, ACS medicinal chemistry letters.

[12]  G. O'Doherty,et al.  Synthesis of SL0101 carbasugar analogues: carbasugars via Pd-catalyzed cyclitolization and post-cyclitolization transformations. , 2010, Organic letters.

[13]  T. K. Eisinger-Mathason,et al.  RSK in tumorigenesis: Connections to steroid signaling , 2010, Steroids.

[14]  Ole Winther,et al.  RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. , 2009, Molecular cell.

[15]  J. Blenis,et al.  The RSK family of kinases: emerging roles in cellular signalling , 2008, Nature Reviews Molecular Cell Biology.

[16]  J. Shabanowitz,et al.  Codependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survival. , 2008, Molecular cell.

[17]  G. O'Doherty,et al.  The de novo synthesis of oligosaccharides: application to the medicinal chemistry SAR-study of digitoxin. , 2008, Current topics in medicinal chemistry.

[18]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[19]  D. Lannigan,et al.  Structural basis for the activity of the RSK-specific inhibitor, SL0101. , 2007, Bioorganic & medicinal chemistry.

[20]  G. O'Doherty,et al.  De novo asymmetric syntheses of SL0101 and its analogues via a palladium-catalyzed glycosylation. , 2006, Organic letters.

[21]  D. Lannigan,et al.  Influence of rhamnose substituents on the potency of SL0101, an inhibitor of the Ser/Thr kinase, RSK. , 2006, Bioorganic & medicinal chemistry.

[22]  Timothy M. Errington,et al.  The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. , 2005, Cancer research.

[23]  G. O'Doherty,et al.  Palladium‐Catalyzed Glycosylation Reaction: De‐Novo Synthesis of Trehalose Analogues , 2005 .

[24]  D. Maloney,et al.  Synthesis of a potent and selective inhibitor of p90 Rsk. , 2005, Organic letters.

[25]  Timothy M. Errington,et al.  Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. , 2005, Cancer research.

[26]  G. O'Doherty,et al.  Synthesis of 7-oxa-phomopsolide E and its C-4 epimer , 2004 .

[27]  C. Proud,et al.  Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.

[28]  V. Young,et al.  Syntheses of four D- and L-hexoses via diastereoselective and enantioselective dihydroxylation reactions. , 2000, Carbohydrate research.

[29]  J. Luche,et al.  Lanthanoids in organic synthesis. 6. Reduction of .alpha.-enones by sodium borohydride in the presence of lanthanoid chlorides: synthetic and mechanistic aspects , 1981 .

[30]  J. Luche,et al.  LANTHANOIDS IN ORGANIC SYNTHESIS. 6. REDUCTION OF α-ENONES BY SODIUM BOROHYDRIDE IN THE PRESENCE OF LANTHANOID CHLORIDES: SYNTHETIC AND MECHANISTIC ASPECTS , 1981 .

[31]  J. Luche,et al.  Reduction of natural enones in the presence of cerium trichloride , 1978 .

[32]  J. Luche.  Lanthanides in organic chemistry. 1. Selective 1,2 reductions of conjugated ketones , 1978 .

[33]  D. Y. Cha,et al.  An improved catalytic OsO4 oxidation of olefins to cis-1,2-glycols using tertiary amine oxides as the oxidant , 1976 .